Master regulators in LUAD

Workflow Surgical Resection EGFR TKI Immunotherapy Data Citation

Identification of master regulators driving disease progression, relapse, and drug resistance in lung adenocarcinoma

---

Abstract

A workflow to identify master regulators driving prognosis in patients with LUAD.

Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, CAS